Skip to content

Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00631982
Enrollment
30
Registered
2008-03-10
Start date
2008-04-30
Completion date
Unknown
Last updated
2008-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Polycystic Ovaries

Keywords

in vitro maturation oocytes

Brief summary

In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

Interventions

PROCEDUREin vitro matuartion of oocytes

in vitro maturation of (immature) oocytes

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Polycystic ovaries * Needing IVF for fertility treatment

Exclusion criteria

* Age above 39

Design outcomes

Primary

MeasureTime frame
maturation rate,18 months

Secondary

MeasureTime frame
Fertilization rate, pregnancy rate18 months

Countries

Israel

Contacts

Primary ContactRaphael Ron - El, MD
+972-8-9779005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026